Silver Book Fact

Antihypertensive therapy has been associated in clinical trials with a 1/3 reduction in stroke incidence, a 1/4 reduction in myocardical infarctions and a more than 1/2 reduction in heart failure.

Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206-52. https://jamanetwork.com/journals/jama/article-abstract/196589?redirect=true

Reference

Title
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
Publication
Hypertension
Publication Date
2003
Authors
Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella
Volume & Issue
Volume 42, Issue 6
Pages
1206-52
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Between 1998 and 2008, the rate of death attributable to cardiovascular disease declined 30.6%.  
  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.  
  • Without antihypertensive therapies, blood pressures (at age 40+) would have been between 10% and 13% higher in 1999-2000. Additionally, 86,000 excess premature deaths from cardiovascular disease would have occurred in…  
  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…